Background/Objectives: Toxoplasma gondii is a major cause of zoonotic infections in both humans and animals, resulting in significant mortality in susceptible species, such as New World primates and marsupials. Toxoplasmosis is particularly concerning in zoos and wildlife reserves, where outbreaks threaten conservation efforts for endangered species. In the absence of a commercially available vaccine against toxoplasmosis for humans and captive wild animals, current prevention strategies are limited to restricting the access of cats to enclosures, controlling rodent populations, and maintaining strict food hygiene. Recent research has shown promising results with an intranasal vaccine (VXN-Toxo) composed of maltodextrin nanoparticles conjugated with a purified, inactivated T. gondii parasite. This experimental vaccine does not pose a risk of causing disease and offers advantages such as better stability compared with live pathogen-based vaccines. Methods: This study presents a large-scale evaluation of the effect of VXN-Toxo administered to captive wildlife across 20 zoos in Europe and the Americas between 2017 and 2025. Seven hundred and eighty-four animals, representing over 58 species (including primates, marsupials, rodents, and felids), were vaccinated without any adverse events reported. Results: Retrospective mortality data from 20 participating zoological institutions revealed an overall 96.7% reduction—and, in many cases, a complete elimination—of toxoplasmosis-associated deaths post vaccination. Conclusions: These results demonstrate, for the first time, consistent and broad-spectrum protection against T. gondii of different strains in a wide array of captive wildlife species. This universal vaccine represents a promising tool for toxoplasmosis prevention in zoological collections, with significant implications for animal health and conservation strategies.
1 September 2019 in Journal of Zoo and Wildlife Medicine
The brown lemur population (Eulemur fulvus spp.) in Mbouzi islet is not native, and was introduced in 1997. Since then, the population has grown. In 2012 the National Council for Protection of Nature of Mayotte requested to remove this population of lemurs from Mbouzi, as they were suspected to be a threat to the protected endemic flora of the islet. The Association Francophone des Vétérinaires de Parcs Zoologiques (French-speaking Zoo Veterinarians Association, AFVPZ) was asked to conduct a biomedical evaluation of the population. Fifty-two animals were captured, anesthetized, and weighed. They all underwent a general physical examination. Feces were sampled for bacterial and parasitological screening. Hair was sampled for genetic studies and blood was sampled for hematology, biochemistry, viral serology, and haemoparasitology. Results showed that three individuals had a positive feces culture for Salmonella enterica and six had Lemuricola or Callistoura parasite infestations. Blood analyses for hematology and biochemistry showed 46 animals with elevated transferrin, 42 with low ferritin levels, 19 with hyperglycemia, and 10 with neutrophilia. Finally, 10 were positive for Toxoplasma serology, one was positive for α herpesvirus, five for pox virus, five for simian virus 40, and two for flavivirus. This publication reports the first complete biomedical evaluation of lemurs on Mayotte Island.
1 June 2017 in Journal of Zoo and Wildlife Medicine
Squamous cell carcinoma (SCC) is well documented in snow leopards (Uncia uncia) and most common locations are oral, facial, or pedal. These two cases illustrate an unusual auricular presentation, which is more often reported in white domestic cats. The animals were aged and presented clinical signs of otitis such as head shaking and ear scratching. Clinical examinations showed auricular canal masses with chronic purulent otitis. In both cases, clinical deterioration led to euthanasia and histology of the ear canal was consistent with SCC and showed numerous vascular emboli. These cases illustrate an unreported aggressive localization for SCC in snow leopards, which should be included in the differential diagnosis of otitis in this species. Auricular SCC may be underdiagnosed as the ear canal is infrequently sampled for histopathology. This auricular localization should be considered when metastases are found upon necropsy without internal primary tumor.
Biological invasions contrast with reintroduction projects, where native species are deliberately returned to their natural habitat to restore local biodiversity. Such a reintroduction project is being carried out in the Upper Rhine Valley with the European pond turtle (Emys orbicularis) in the transbordering region between Lauterbourg (France) and Neuburg am Rhein (Germany), hereafter referred as Neu-Woerr. Several ponds have been created to benefit the dispersal of reintroduced turtles. However, this pondscape has been recently widely invaded by the calico crayfish (Faxonius immunis) and partly by the zebra mussel (Dreissena polymorpha). These two invasive non-native species decrease the overall habitat quality due to the massive exploitation of phytoplankton by the zebra mussel as well as macrophytes and macroinvertebrates by the calico crayfish. However, these invasive non-native species are also potential novel prey for the reintroduced turtles. Here, we investigated the trophic interactions under captive conditions between the turtle and the two invasive non-native species. We conducted prey choice tests of turtles with calico crayfish of different sex, size, and shell hardness, as well as with zebra mussels of different size. Additionally, faecal samples of wild caught turtles on Neu-Woerr were sampled and analysed for calico crayfish DNA. Our results demonstrated that the turtles were capable of preying on the calico crayfish in the wild and in captivity, preferring small crayfish individuals, with no sexual preference for the less aggressive female crayfish. For the zebra mussels, turtles preyed preferably on small alive individuals, while they also preyed on larger, yet dead mussels. This study provides new insights into the feeding ecology of the European pond turtle and highlights added benefits and values of reintroduction projects when the reintroduced species additionally acts as a novel predator of invasive species.
The pace of life syndrome hypothesis (POLS) suggests that organisms’ life history, physiological and behavioural traits should co-evolve. In this framework, how glycaemia (i.e., blood glucose levels) and its reaction with proteins and other compounds (i.e. glycation) covary with life history traits remain relatively under-investigated, despite the well documented consequences of glucose and glycation on ageing, and therefore potentially on life history evolution. Birds are particularly relevant in this context given that they have the highest blood glucose levels within vertebrates and still higher mass-adjusted longevity when compared to organisms with similar physiology as mammals. We thus performed a comparative analysis on glucose and albumin glycation rates of 88 bird species from 22 orders, in relation to life history traits (body mass, clutch mass, maximum lifespan and developmental time) and diet. Glucose levels correlated positively with albumin glycation rates in a non-linear fashion, suggesting resistance to glycation in species with higher glucose levels. Plasma glucose levels decreased with increasing body mass but, contrary to what is predicted to the POLS hypothesis, glucose levels increased with maximum lifespan before reaching a plateau. Finally, terrestrial carnivores showed higher albumin glycation compared to omnivores despite not showing higher glucose, which we discuss may be related to additional factors as differential antioxidant levels or dietary composition in terms of fibres or polyunsaturated fatty acids. These results increase our knowledge about the diversity of glycaemia and glycation patterns across birds, pointing towards the existence of glycation resistance mechanisms within comparatively high glycaemic birds.
17 November 2025 in Journal of Zoo and Wildlife Medicine
The European pond turtle (Emys orbicularis) is an endangered species occurring in large parts of Europe, northern Africa, and western Asia. The species is subject to a number of translocation-based conservation initiatives that rely on collections from private and institutional breeding facilities. So far, relatively little work has been done on infectious diseases in this species. During routine health screening in two European pond turtle collections, one of reintroduced turtles in France and one of head-started juveniles in Germany, oral and cloacal swabs from 47 clinically healthy European pond turtles were screened for the presence of adenoviruses, herpesviruses, ranaviruses, and mycoplasma by PCR. Adenoviruses and mycoplasma were detected in 35 (74.5%) and 12 (25.5%) turtles, respectively, whereas no ranaviruses or herpesviruses were detected in any tested individuals. Both adenoviruses and mycoplasma were concurrently found in 11 (23.4%) individuals, but there was no significant relationship between infection with these two pathogens. Sequencing of several of the PCR products revealed two different adenoviruses, the majority (90% of the 20 sequenced) being a novel testadenovirus (Emys testadenovirus 1), while a virus closely related to the previously described box turtle testadenovirus 1 was found in two animals. The mycoplasmas were closely related to previously described mycoplasmas from emydid turtles. Additional work is needed to understand the diversity and impacts of viral and bacterial pathogens on European pond turtles. Systematic standard testing and quarantine protocols should be established for this species, especially for translocation-based conservation initiatives.